Side-by-Side Comparison
| Metric | Cholesgen | remynd |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2002 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Belgium |
| Employees | ||
| Employees | Not tracked yet | 30 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Manufacturing |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $100.00M | $24.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Not tracked yet | Development of oral treatments for neurodegenerative diseases, Contract Research Organization services, Proof-of-concept studies in mouse models |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biopharmaceutical researchers, Drug developers, Healthcare stakeholders |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Research, Drug Development, Innovative Drugs, Disease Targets, Biochemistry, Medicinal Chemistry, Clinical Translational Medicine, Pharmaceutical Industry, Medical Innovation | Not tracked yet |
| Website | ||
| Website | cholesgen.com | remynd.com |
About Cholesgen
Cholesgen is a biopharmaceutical company founded in 2021 with a mission to revolutionize medicine through innovative drug development and advanced biopharmaceutical research. The company's dedication to pioneering new disease targets based on biochemistry, disease biology, medicinal chemistry, and c...
About remynd
remynd is a clinical-stage biotechnology company focused on innovating oral therapeutics for neurodegenerative diseases like Alzheimer’s and Huntington’s disease. Founded in 2002 and headquartered in Belgium, the company strives to tackle disease mechanisms, aiming to enhance neuronal function and c...
We will tell you when either one moves
BounceWatch watches Cholesgen and remynd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cholesgen and remynd — by email.
Frequently Asked Questions
Compare Cholesgen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cholesgen on 12 Sep 2024, and remynd on 23 Feb 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.